ELPLAT Side Effects

7009196-9 | Silent Myocardial Infarction
on Sep 14, 2010 Female patient from JAPAN , 61 years of age, was diagnosed with large intestine carcinoma and was treated with Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: silent myocardial infarction. Elplat dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), XELODA (View Xeloda Review and Xeloda Label ).

7007342-4 | Liver Abscess, Pyrexia
Patient was taking Elplat (View Usage). Patient had the following side effects: liver abscess, pyrexia on Sep 14, 2010 from JAPAN Additional patient health information: Male patient , 57 years of age, was diagnosed with colon cancer metastatic and. Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), AVASTIN (View Avastin Review and Avastin Label ). Patient was hospitalized.

6998390-9 | Anaphylactic Shock, Disseminated Intravascular Coagulation, Pancreatitis
Adverse event was reported on Sep 09, 2010 by a Female patient taking Elplat (View Usage) (Dosage: ) was diagnosed with colon cancer and. Location: JAPAN , 84 years of age, weighting 81.57 lb, After Elplat was administered, patient had the following side effects: anaphylactic shock, disseminated intravascular coagulation, pancreatitis. During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6998337-5 | Anaphylactic Shock
on Sep 08, 2010 Female patient from JAPAN , 60 years of age, weighting 99.21 lb, was diagnosed with colon cancer and was treated with Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Elplat dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ).


6992139-1 | Fasciitis, Rectal Perforation
on Sep 06, 2010 Male patient from JAPAN , 60 years of age, was diagnosed with rectal cancer recurrent and was treated with Elplat (View Usage). Patient had the following side effects: fasciitis, rectal perforation. Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), AVASTIN (View Avastin Review and Avastin Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6987643-6 | Anaphylactic Shock, Disseminated Intravascular Coagulation
Patient was taking Elplat (View Usage). After Elplat was administered, patient had the following side effects: anaphylactic shock, disseminated intravascular coagulation on Sep 02, 2010 from JAPAN Additional patient health information: Female patient , 86 years of age, weighting 81.57 lb, was diagnosed with colon cancer and. Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6972985-0 | Gastrointestinal Perforation
Adverse event was reported on Aug 30, 2010 by a Female patient taking Elplat (View Usage) (Dosage: ) was diagnosed with large intestine carcinoma and. Location: JAPAN , 59 years of age, Patient experienced the following unwanted or unexpected effects: gastrointestinal perforation. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ).

6968311-3 | Gingival Bleeding, Haemorrhage Urinary Tract, Vitreous Haemorrhage
on Aug 25, 2010 Female patient from JAPAN , 61 years of age, was diagnosed with colon cancer and was treated with Elplat (View Usage). Patient had the following side effects: gingival bleeding, haemorrhage urinary tract, vitreous haemorrhage. Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6967409-3 | Anaphylactic Shock, Disseminated Intravascular Coagulation
on Sep 02, 2010 Female patient from JAPAN , 84 years of age, was diagnosed with large intestine carcinoma and was treated with Elplat (View Usage). After Elplat was administered, patient had the following side effects: anaphylactic shock, disseminated intravascular coagulation. Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), AVASTIN (View Avastin Review and Avastin Label ).

6967267-7 | Abdominal Distension, Ascites, Epistaxis, Oedema, Rash, Renal Failure Acute
Patient was taking Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, ascites, epistaxis, oedema, rash (What is rash?), renal failure acute on Aug 26, 2010 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with colon cancer recurrent and. Elplat dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ), PYDOXAL (View Pydoxal Review and Pydoxal Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized and became disabled.

6944676-3 | Abdominal Pain, Abscess, Anal Fistula, C-reactive Protein Increased, Diarrhoea, Gastrointestinal Perforation, Musculoskeletal Pain, Nausea, Pyrexia
Adverse event was reported on Aug 23, 2010 by a Male patient taking Elplat (View Usage) (Dosage: ) was diagnosed with rectal cancer recurrent and. Location: JAPAN , 50 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), abscess (What is abscess?), anal fistula, c-reactive protein increased, diarrhoea, gastrointestinal perforation, musculoskeletal pain, nausea (What is nausea?), pyrexia. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), KYTRIL (View Kytril Review and Kytril Label ).

6940116-9 | Cerebral Infarction
on Aug 13, 2010 Female patient from JAPAN , 66 years of age, was diagnosed with colon cancer and was treated with Elplat (View Usage). After Elplat was administered, patient had the following side effects: cerebral infarction. Elplat dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ). Patient was hospitalized and became disabled.

6920908-2 | Adams-stokes Syndrome
on Aug 02, 2010 Male patient from JAPAN , 70 years of age, weighting 116.6 lb, was diagnosed with gastric cancer, hyperuricaemia, cerebral infarction, hypertension, arteriosclerosis obliterans and was treated with Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: adams-stokes syndrome. Elplat dosage: . During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ), TENORMIN (View Tenormin Review and Tenormin Label ), LIMAPROST (View Limaprost Review and Limaprost Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ). Patient was hospitalized.

6920891-X | Gastrointestinal Necrosis
Patient was taking Elplat (View Usage). Patient had the following side effects: gastrointestinal necrosis on Aug 02, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, weighting 116.6 lb, was diagnosed with gastric cancer, hyperuricaemia, cerebral infarction, hypertension, arteriosclerosis obliterans and. Elplat dosage: . During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ), TENORMIN (View Tenormin Review and Tenormin Label ), LIMAPROST (View Limaprost Review and Limaprost Label ), PLETAL (View Pletal Review and Pletal Label ). Patient was hospitalized.

6918863-4 | Altered State Of Consciousness, Hyperammonaemia, Portal Hypertension, Splenomegaly
Adverse event was reported on Jul 30, 2010 by a Female patient taking Elplat (View Usage) (Dosage: ) was diagnosed with rectal cancer and. Location: JAPAN , 55 years of age, weighting 114.6 lb, After Elplat was administered, patient had the following side effects: altered state of consciousness, hyperammonaemia, portal hypertension, splenomegaly. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ), AMINOLEBAN (View Aminoleban Review and Aminoleban Label ), AMOBAN (View Amoban Review and Amoban Label ), NEUROVITAN (View Neurovitan Review and Neurovitan Label ), MAGLAX (View Maglax Review and Maglax Label ).

6918070-5 | Shock Haemorrhagic
on Jul 30, 2010 Male patient from JAPAN , 68 years of age, weighting 130.1 lb, was diagnosed with gastric cancer, cancer pain, cholangitis, nausea (What is nausea?) and was treated with Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: shock haemorrhagic. Elplat dosage: . During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), TS 1 (View Ts-1 Review and Ts-1 Label ), CALONAL (View Calonal Review and Calonal Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), OPSO DAINIPPON (View Opso Dainippon Review and Opso Dainippon Label ), CRAVIT (View Cravit Review and Cravit Label ), NOVAMIN (View Novamin Review and Novamin Label ). Patient was hospitalized.

6913439-7 | Adverse Event, Blood Potassium Increased
on Jul 28, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with colon cancer metastatic, hypertension and was treated with Elplat (View Usage). Patient had the following side effects: adverse event, blood potassium increased. Elplat dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), XELODA (View Xeloda Review and Xeloda Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), SALOBEL (View Salobel Review and Salobel Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DIOVANE (View Diovane Review and Diovane Label ). Patient was hospitalized.

6910484-2 | Ascites, Blood Albumin Decreased, Blood Urine Present, Eczema, Epistaxis, Oedema, Protein Urine, Purpura, Rash
Patient was taking Elplat (View Usage). After Elplat was administered, patient had the following side effects: ascites, blood albumin decreased, blood urine present, eczema (What is eczema?), epistaxis, oedema, protein urine, purpura, rash (What is rash?) on Jul 26, 2010 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with colon cancer and. Elplat dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ), MYSLEE (View Myslee Review and Myslee Label ), PROTECADIN (View Protecadin Review and Protecadin Label ). Patient was hospitalized.

6907828-4 | Incisional Hernia, Neuropathy Peripheral, Wound Dehiscence
Adverse event was reported on Jul 28, 2010 by a Male patient taking Elplat (View Usage) (Dosage: ) . Location: JAPAN , 69 years of age, Patient experienced the following unwanted or unexpected effects: incisional hernia, neuropathy peripheral, wound dehiscence. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ). Patient was hospitalized.

6907664-9 | Incisional Hernia, Neuropathy Peripheral, Post Procedural Bile Leak
on Jul 28, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with colon cancer metastatic and was treated with Elplat (View Usage). Patient had the following side effects: incisional hernia, neuropathy peripheral, post procedural bile leak. Elplat dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6896401-2 | Adverse Reaction, Cerebral Infarction
on Jul 26, 2010 Female patient from JAPAN , 60 years of age, was diagnosed with large intestine carcinoma and was treated with Elplat (View Usage). After Elplat was administered, patient had the following side effects: adverse reaction, cerebral infarction. Elplat dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ).

6887878-7 | Shock
Patient was taking Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: shock on Jul 21, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, was diagnosed with colon cancer and. Elplat dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ).

6883921-X | Liver Abscess
Adverse event was reported on Jul 21, 2010 by a Female patient taking Elplat (View Usage) (Dosage: ) was diagnosed with colon cancer metastatic and. Location: JAPAN , 73 years of age, Patient had the following side effects: liver abscess. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6880233-5 | Liver Abscess
on Jul 19, 2010 Male patient from JAPAN , 57 years of age, was diagnosed with colon cancer metastatic and was treated with Elplat (View Usage). After Elplat was administered, patient had the following side effects: liver abscess. Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), AVASTIN (View Avastin Review and Avastin Label ). Patient was hospitalized.

6880213-X | Incisional Hernia, Neuropathy Peripheral, Post Procedural Bile Leak
on Jul 16, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with colon cancer metastatic and was treated with Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: incisional hernia, neuropathy peripheral, post procedural bile leak. Elplat dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6844858-5 | Hyperammonaemia
Patient was taking Elplat (View Usage). Patient had the following side effects: hyperammonaemia on Jul 05, 2010 from JAPAN Additional patient health information: Female patient , 47 years of age, weighting 99.21 lb, was diagnosed with rectal cancer and. Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), AVASTIN (View Avastin Review and Avastin Label ). Patient was hospitalized.

6826576-2 | Adams-stokes Syndrome
Adverse event was reported on Jun 29, 2010 by a Male patient taking Elplat (View Usage) (Dosage: ) was diagnosed with gastric cancer, hyperuricaemia, cerebral infarction, hypertension, arteriosclerosis obliterans and. Location: JAPAN , 70 years of age, weighting 116.6 lb, After Elplat was administered, patient had the following side effects: adams-stokes syndrome. During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ), TENORMIN (View Tenormin Review and Tenormin Label ), LIMAPROST (View Limaprost Review and Limaprost Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ). Patient was hospitalized.

6826575-0 | Gastrointestinal Necrosis
on Jun 29, 2010 Male patient from JAPAN , 70 years of age, weighting 116.6 lb, was diagnosed with gastric cancer, hyperuricaemia, cerebral infarction, hypertension, arteriosclerosis obliterans and was treated with Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal necrosis. Elplat dosage: . During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TRICHLORMETHIAZIDE (View Trichlormethiazide Review and Trichlormethiazide Label ), TENORMIN (View Tenormin Review and Tenormin Label ), LIMAPROST (View Limaprost Review and Limaprost Label ), PLETAL (View Pletal Review and Pletal Label ). Patient was hospitalized.

6816848-X | Pulmonary Tuberculosis
on Jun 22, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with rectal cancer and was treated with Elplat (View Usage). Patient had the following side effects: pulmonary tuberculosis. Elplat dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ).

6816498-5 | Shock Haemorrhagic
Patient was taking Elplat (View Usage). After Elplat was administered, patient had the following side effects: shock haemorrhagic on Jun 24, 2010 from JAPAN Additional patient health information: Male patient , 68 years of age, weighting 130.1 lb, was diagnosed with gastric cancer, cancer pain, cholangitis, nausea (What is nausea?) and. Elplat dosage: . During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), TS 1 (View Ts-1 Review and Ts-1 Label ), CALONAL (View Calonal Review and Calonal Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), OPSO DAINIPPON (View Opso Dainippon Review and Opso Dainippon Label ), CRAVIT (View Cravit Review and Cravit Label ), NOVAMIN (View Novamin Review and Novamin Label ). Patient was hospitalized.

6809889-X | Shock Haemorrhagic
Adverse event was reported on Jun 22, 2010 by a Male patient taking Elplat (View Usage) (Dosage: ) was diagnosed with gastric cancer and. Location: JAPAN , 68 years of age, weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: shock haemorrhagic. During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), TS 1 (View Ts-1 Review and Ts-1 Label ). Patient was hospitalized.

6784077-4 | Antibiotic Resistant Staphylococcus Test Positive, Disseminated Intravascular Coagulation, Dyslalia, Epistaxis, Face Oedema, Hypoaesthesia, Laryngeal Oedema, Multi-organ Failure, Neutrophil Count Decreased
on Jun 17, 2010 Male patient from JAPAN , 68 years of age, was diagnosed with large intestine carcinoma and was treated with Elplat (View Usage). Patient had the following side effects: antibiotic resistant staphylococcus test positive, disseminated intravascular coagulation, dyslalia, epistaxis, face oedema, hypoaesthesia, laryngeal oedema, multi-organ failure, neutrophil count decreased. Elplat dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ). Patient was hospitalized.

6771947-6 | Abdominal Abscess, Infection, Rectal Perforation
on Jun 11, 2010 Female patient from JAPAN , 60 years of age, weighting 88.18 lb, was diagnosed with rectal cancer and was treated with Elplat (View Usage). After Elplat was administered, patient had the following side effects: abdominal abscess, infection (What is infection?), rectal perforation. Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6769610-0 | Anaphylactic Shock, Cardiac Arrest
Patient was taking Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?) on Jun 02, 2010 from JAPAN Additional patient health information: Male patient , 54 years of age, . Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6763036-1 | Face Oedema, Glossopharyngeal Nerve Paralysis, Laryngeal Oedema, Photosensitivity Reaction
Adverse event was reported on May 28, 2010 by a Male patient taking Elplat (View Usage) (Dosage: ) was diagnosed with large intestine carcinoma and. Location: JAPAN , 68 years of age, Patient had the following side effects: face oedema, glossopharyngeal nerve paralysis, laryngeal oedema, photosensitivity reaction. During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6746852-1 | Anaphylactic Shock, Blood Pressure Decreased, Prinzmetal Angina
on May 17, 2010 Male patient from JAPAN , 73 years of age, weighting 114.6 lb, was diagnosed with rectal cancer and was treated with Elplat (View Usage). After Elplat was administered, patient had the following side effects: anaphylactic shock, blood pressure decreased, prinzmetal angina. Elplat dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), ORGADRONE (View Orgadrone Review and Orgadrone Label ), DOPAMINE HYDROCHLORIDE (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ). Patient was hospitalized.

6744180-1 | Hepatic Encephalopathy
on May 17, 2010 Male patient from JAPAN , 66 years of age, was diagnosed with dyspepsia, gastritis, constipation (What is constipation?), insomnia and was treated with Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic encephalopathy. Elplat dosage: . During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), EXCELASE (View Excelase Review and Excelase Label ), SEVEN EP (View Seven Ep Review and Seven Ep Label ), TAKEPRON (View Takepron Review and Takepron Label ), LASIX (View Lasix Review and Lasix Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), AMOBAN (View Amoban Review and Amoban Label ). Patient was hospitalized.

6744173-4 | Decreased Appetite, Gastrointestinal Motility Disorder
Patient was taking Elplat (View Usage). Patient had the following side effects: decreased appetite, gastrointestinal motility disorder on May 17, 2010 from JAPAN Additional patient health information: Male patient , 68 years of age, weighting 130.1 lb, was diagnosed with rectal cancer, palliative care (What is palliative care?) and. Elplat dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), AVASTIN (View Avastin Review and Avastin Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ), KYTRIL (View Kytril Review and Kytril Label ), GASTER D (View Gaster D Review and Gaster D Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ).

6743795-4 | Embolism, Gastrointestinal Perforation
Adverse event was reported on May 25, 2010 by a Female patient taking Elplat (View Usage) (Dosage: ) was diagnosed with colon cancer metastatic and. Location: JAPAN , 43 years of age, weighting 134.0 lb, After Elplat was administered, patient had the following side effects: embolism, gastrointestinal perforation. During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), PARIET (View Pariet Review and Pariet Label ).

6728365-6 | Hepatic Encephalopathy
on May 17, 2010 Male patient from JAPAN , 66 years of age, weighting 162.0 lb, was diagnosed with insomnia, dyspepsia, gastritis, oedema, constipation (What is constipation?) and was treated with Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic encephalopathy. Elplat dosage: . During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), EXCELASE (View Excelase Review and Excelase Label ), SEVEN EP (View Seven Ep Review and Seven Ep Label ), TAKEPRON (View Takepron Review and Takepron Label ), LASIX (View Lasix Review and Lasix Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

6722152-0 | Neuropathy Peripheral
on Apr 30, 2010 Female patient from JAPAN , 63 years of age, was diagnosed with rectal cancer and was treated with Elplat (View Usage). Patient had the following side effects: neuropathy peripheral. Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

6713876-X | Anaphylactic Shock, Venous Thrombosis, Wound Decomposition
Patient was taking Elplat (View Usage). After Elplat was administered, patient had the following side effects: anaphylactic shock, venous thrombosis, wound decomposition on May 04, 2010 from JAPAN Additional patient health information: Male patient , 58 years of age, was diagnosed with rectal cancer metastatic and. Elplat dosage: . During the same period patient was treated with ISOVORIN (View Isovorin Review and Isovorin Label ), AVASTIN (View Avastin Review and Avastin Label ), IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6713718-2 | Gastrointestinal Perforation, Haemoglobin Decreased, Ileus
Adverse event was reported on May 04, 2010 by a Male patient taking Elplat (View Usage) (Dosage: ) was diagnosed with colon cancer, prophylaxis of nausea and vomiting, insomnia, constipation (What is constipation?) and. Location: JAPAN , 55 years of age, weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: gastrointestinal perforation, haemoglobin decreased, ileus. During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), TS 1 (View Ts-1 Review and Ts-1 Label ), AVASTIN (View Avastin Review and Avastin Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), PURSENNID /SCH/ (View Pursennid /sch/ Review and Pursennid /sch/ Label ). Patient was hospitalized.

6710045-4 | Abdominal Pain Upper, Biliary Colic, Cholelithiasis, Porcelain Gallbladder
on Apr 29, 2010 Male patient from JAPAN , 63 years of age, was diagnosed with colon cancer metastatic, large intestine carcinoma and was treated with Elplat (View Usage). Patient had the following side effects: abdominal pain upper, biliary colic, cholelithiasis, porcelain gallbladder. Elplat dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

6708642-5 | Hepatic Encephalopathy
on Apr 30, 2010 Male patient from JAPAN , 66 years of age, was diagnosed with dyspepsia, gastritis, constipation (What is constipation?), insomnia and was treated with Elplat (View Usage). After Elplat was administered, patient had the following side effects: hepatic encephalopathy. Elplat dosage: . During the same period patient was treated with TS 1 (View Ts-1 Review and Ts-1 Label ), EXCELASE (View Excelase Review and Excelase Label ), SEVEN EP (View Seven Ep Review and Seven Ep Label ), TAKEPRON (View Takepron Review and Takepron Label ), LASIX (View Lasix Review and Lasix Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), AMOBAN (View Amoban Review and Amoban Label ). Patient was hospitalized.

6706442-3 | Blood Pressure Decreased, Prinzmetal Angina
Patient was taking Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, prinzmetal angina on Apr 21, 2010 from JAPAN Additional patient health information: Male patient , 73 years of age, weighting 114.6 lb, was diagnosed with rectal cancer and. Elplat dosage: . During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ). Patient was hospitalized.

6706368-5 | Diarrhoea, Disseminated Intravascular Coagulation, Renal Failure Acute
Adverse event was reported on Apr 21, 2010 by a Male patient taking Elplat (View Usage) (Dosage: ) was diagnosed with colon cancer and. Location: JAPAN , 74 years of age, Patient had the following side effects: diarrhoea, disseminated intravascular coagulation, renal failure acute. During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ).

6706255-2 | Anaphylactic Shock
on Apr 27, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with colon cancer and was treated with Elplat (View Usage). After Elplat was administered, patient had the following side effects: anaphylactic shock. Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), AVASTIN (View Avastin Review and Avastin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

6704422-5 | Necrotising Fasciitis
on Apr 19, 2010 Male patient from JAPAN , 66 years of age, weighting 110.2 lb, was diagnosed with rectal cancer and was treated with Elplat (View Usage). Patient experienced the following unwanted or unexpected effects: necrotising fasciitis. Elplat dosage: . During the same period patient was treated with CALCIUM LEVOFOLINATE (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), KYTRIL (View Kytril Review and Kytril Label ).

6704264-0 | Gastrointestinal Motility Disorder
Patient was taking Elplat (View Usage). Patient had the following side effects: gastrointestinal motility disorder on Apr 21, 2010 from JAPAN Additional patient health information: Male patient , 68 years of age, weighting 130.1 lb, was diagnosed with rectal cancer, palliative care (What is palliative care?) and. Elplat dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), AVASTIN (View Avastin Review and Avastin Label ), DEXAMETHASONE SODIUM PHOSPHATE (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label ), KYTRIL (View Kytril Review and Kytril Label ), GASTER D (View Gaster D Review and Gaster D Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ).